Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome:: Baseline results from LOGIC (longitudinal outcomes study of gastrointestinal symptoms in Canada), a naturalistic study

被引:145
作者
Pare, Pierre
Gray, James
Lam, Sy
Balshaw, Robert
Khorasheh, Shideh
Barbeau, Martin
Kelly, Suzanne
McBurney, Christopher R.
机构
[1] Ctr Hosp Affilie Univ Quebec, Hop St Sacrement, Quebec City, PQ G1S 4L8, Canada
[2] Univ British Columbia, Dept Gastroenterol, Vancouver, BC V5Z 1M9, Canada
[3] Calgary Hlth Reg Author, Calgary, AB, Canada
[4] Syreon Corp, Vancouver, BC, Canada
[5] Novartis, Montreal, PQ, Canada
[6] Novartis Pharma AG, Basel, Switzerland
关键词
IBS; quality of life; work productivity; resource utilization; IBS-QOL; WPAI; EQ-5D;
D O I
10.1016/j.clinthera.2006.10.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Abdominal pain/discomfort, bloating, and constipation are gastrointestinal dysmotility and sensory symptoms associated with irritable bowel syndrome (IBS). No studies have followed patients with IBS symptoms for 1 year under conditions of routine clinical practice to assess prospectively the impact of treatments on health outcomes. Objective: The objective of this ongoing, naturalistic study is to assess the long-term impact of IBS treatments on quality of life (QOL), work productivity, and resource utilization. This report describes the baseline characteristics and patterns of care of the patients enrolled in this study. Methods: Patients with physician-diagnosed IBS symptoms were enrolled from 147 physician sites across Canada between May 4, 2004, and March 31, 2005. Clinical data were collected at baseline and at the end of the 12-month follow-up (patients were followed for 1 year between May 4, 2005, and March 31, 2006). Patient-reported outcomes were collected at baseline and at months 1, 2, 6, 9, and 12. Health-related QOL, health status, and work productivity were assessed with the IBS-QOL, a 5-item EuroQol descriptive system, and Work Productivity and Activity Impairment questionnaires, respectively. A resource utilization questionnaire elicited information on physician visits, treatments, and procedures. Baseline data are reported here. Results: Data were obtained from 1555 patients; 85.1% (1320/1552) were women. Patients had a mean (SD) age of 45.8 (15.0) years and mean (SD) duration of IBS symptoms of 11.4 (11.5) years. Self-reported bowel patterns were predominantly constipation (41.0%, 587/1433) and constipation alternating with diarrhea (39.4%, 564/1433); 60.3% (93811555) of subjects used 3 IBS treatments in the previous 4 weeks. Approximately 50% of all patients reported distress "quite a bit" or "extremely" for abdominal pain, gas, bloating, and constipation. The mean overall IBS-QOL score (0-100 scale, with 0 indicating poor QOL) was 66.3; food avoidance (51.8) and health worry (59.3) were the most serious concerns. Patients reported 5.6% work absenteeism, 31.4% presenteeism, and 34.6% overall work productivity loss, equivalent to 13.8 hours lost productivity per 40-hour workweek. Conclusions: The baseline data from this ongoing, prospective, naturalistic study are consistent with previous findings that suggested significant use of health care resources with concomitant low QOL and decreased work productivity in patients with IBS symptoms. (Clin Ther. 2006;28:1726-1735) Copyright (c) 2006 Excerpta Medica, Inc.
引用
收藏
页码:1726 / 1735
页数:10
相关论文
共 49 条
[11]   IRRITABLE-BOWEL-SYNDROME IN OFFICE-BASED PRACTICE IN THE UNITED-STATES [J].
EVERHART, JE ;
RENAULT, PF .
GASTROENTEROLOGY, 1991, 100 (04) :998-1005
[12]   Health-related quality of life associated with irritable bowel syndrome: Comparison with other chronic diseases [J].
Frank, L ;
Kleinman, L ;
Rentz, A ;
Ciesla, G ;
Kim, JJ ;
Zacker, C .
CLINICAL THERAPEUTICS, 2002, 24 (04) :675-689
[13]  
Frissora Christine L, 2005, MedGenMed, V7, P71
[14]   The impact of irritable bowel syndrome on health-related quality of life [J].
Gralnek, IM ;
Hays, RD ;
Kilbourne, A ;
Naliboff, B ;
Mayer, EA .
GASTROENTEROLOGY, 2000, 119 (03) :654-660
[15]   Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom [J].
Hahn, BA ;
Yan, SK ;
Strassels, S .
DIGESTION, 1999, 60 (01) :77-81
[16]   Health related quality of life in individuals with asthma related symptoms [J].
Hazel, M ;
Frank, T ;
Frank, P .
RESPIRATORY MEDICINE, 2003, 97 (11) :1211-1218
[17]   The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects [J].
Hungin, APS ;
Whorwell, PJ ;
Tack, J ;
Mearin, F .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (05) :643-650
[18]  
Hurst NP, 1997, BRIT J RHEUMATOL, V36, P551
[19]   Systematic review: the economic impact of irritable bowel syndrome [J].
Inadomi, JM ;
Fennerty, MB ;
Bjorkman, D .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (07) :671-682
[20]   Clinical economics review: Gastrointestinal disease in primary care [J].
Jones, RH .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (03) :233-239